146 related articles for article (PubMed ID: 10524687)
61. A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis.
Wallace D; Goldfinger D; Lowe C; Nichols S; Weiner J; Brachman M; Klinenberg JR
N Engl J Med; 1982 Jun; 306(23):1406-10. PubMed ID: 7043264
[No Abstract] [Full Text] [Related]
62. Apheresis: clinical response to patients unresponsive to conventional therapy.
Sakamoto H; Takaoka T; Usami M; Emura M; Okabe K; Matsushita M; Smith JW; Malchesky PS; Nose Y
Trans Am Soc Artif Intern Organs; 1985; 31():704-10. PubMed ID: 3837535
[TBL] [Abstract][Full Text] [Related]
63. A double-blind comparison of high and low doses of levamisole in rheumatoid arthritis.
Pinals RS; Robertson F; Blechman WJ
J Rheumatol; 1981; 8(6):949-51. PubMed ID: 7328569
[TBL] [Abstract][Full Text] [Related]
64. [The immunomodulating action of extracorporeal treatment methods and the late effect from their use in patients with rheumatoid arthritis].
Siuniakova EV; Borisova AM; Martynov AI; Pinegin BV; Podobin NP; Tverskoĭ KA
Ter Arkh; 1992; 64(5):51-3. PubMed ID: 1455375
[TBL] [Abstract][Full Text] [Related]
65. [Comparative evaluation of the effectiveness of plasmapheresis and lymphocytoplasmapheresis in the combined treatment of rheumatoid arthritis].
Mikhaĭlova NA; Mazneva LM; Konovalov GA; Demidova TV; Kulakov GP
Ter Arkh; 1986; 58(8):105-11. PubMed ID: 3764751
[TBL] [Abstract][Full Text] [Related]
66. Effectiveness of Acupuncture on Pain, Functional Disability, and Quality of Life in Rheumatoid Arthritis of the Hand: Results of a Double-Blind Randomized Clinical Trial.
Seca S; Patrício M; Kirch S; Franconi G; Cabrita AS; Greten HJ
J Altern Complement Med; 2019 Jan; 25(1):86-97. PubMed ID: 30328699
[TBL] [Abstract][Full Text] [Related]
67. [The effect of hemosorption and plasmapheresis on fibrinogen-125I kinetics in patients with rheumatoid arthritis].
Bazhanov AN; Golubeva LV; Trusov VV
Ter Arkh; 1995; 67(6):50-2. PubMed ID: 7667782
[TBL] [Abstract][Full Text] [Related]
68. [Lymphocytapheresis in the treatment of chronic polyarthritis. Effect on clinical and laboratory chemical parameters and lymphocyte function].
Krüger K; Demant T; Kellner H; Schattenkirchner M
Z Rheumatol; 1987; 46(6):303-10. PubMed ID: 3439364
[TBL] [Abstract][Full Text] [Related]
69. Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.
Griffiths RI; Slurzberg JE
Ther Apher; 2001 Apr; 5(2):105-10. PubMed ID: 11354293
[TBL] [Abstract][Full Text] [Related]
70. [The joint use of hemosorption and plasmapheresis in the combined treatment of rheumatoid arthritis patients].
Trusov VV; Bazhenov AN; Stoliarov DD; Odnopozov II
Ter Arkh; 1999; 71(5):22-5. PubMed ID: 10399225
[TBL] [Abstract][Full Text] [Related]
71. [Plasmapheresis for patients with RA].
Tsuda H; Yokoyama M; Hashimoto H; Hirose S
Nihon Rinsho; 1992 Mar; 50(3):543-6. PubMed ID: 1588745
[TBL] [Abstract][Full Text] [Related]
72. [Cascade use of plasmapheresis and plasma filtration in the treatment of rheumatoid arthritis].
Mikhaĭlova NA; Konovalov GA; Mazneva LM; Denisov AIu; Demidova TV
Ter Arkh; 1987; 59(6):67-70. PubMed ID: 3629502
[TBL] [Abstract][Full Text] [Related]
73. Vasculitis following treatment of rheumatoid arthritis with extracorporeal staphylococcal protein a immunoadsorption column (prosorba).
Scroggie D; Harris MD; Abel M; Sakai L; Arroyo R
J Clin Rheumatol; 2001 Aug; 7(4):238-41. PubMed ID: 17039141
[TBL] [Abstract][Full Text] [Related]
74. [A case of malignant rheumatoid arthritis with long-term improvement by regular use of cryofiltration plasmapheresis].
Ushiyama O; Hiida M; Toyoshima H; Kaneoka H; Ohta A; Yamaguchi M
Ryumachi; 1993 Apr; 33(2):149-55. PubMed ID: 8316905
[TBL] [Abstract][Full Text] [Related]
75. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
76. [Controlled (double-blind) trial of isolated irradiation of the blood in rheumatoid arthritis].
Ivanova RL; Benenson EV
Revmatologiia (Mosk); 1984; (2):36-8. PubMed ID: 6382540
[No Abstract] [Full Text] [Related]
77. MS characterization of apheresis samples from rheumatoid arthritis patients for the improvement of immunoadsorption therapy - a pilot study.
Kienbaum M; Koy C; Montgomery HV; Drynda S; Lorenz P; Illges H; Tanaka K; Kekow J; Guthke R; Thiesen HJ; Glocker MO
Proteomics Clin Appl; 2009 Jul; 3(7):797-809. PubMed ID: 21136988
[TBL] [Abstract][Full Text] [Related]
78. A randomized, controlled trial of interferon-beta-1a (Avonex(R)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626].
Genovese MC; Chakravarty EF; Krishnan E; Moreland LW
Arthritis Res Ther; 2004; 6(1):R73-R77. PubMed ID: 14979940
[TBL] [Abstract][Full Text] [Related]
79. Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis.
Poullin P; Announ N; Mugnier B; Guis S; Roudier J; Lefèvre P
Joint Bone Spine; 2005 Mar; 72(2):101-3. PubMed ID: 15797486
[No Abstract] [Full Text] [Related]
80. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis.
Drevlow BE; Lovis R; Haag MA; Sinacore JM; Jacobs C; Blosche C; Landay A; Moreland LW; Pope RM
Arthritis Rheum; 1996 Feb; 39(2):257-65. PubMed ID: 8849376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
